Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

CTO vs XRN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CTO Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 9–1 Matrix Metrics)

CTO Overall Winner 6-Pillar Tally: CTO 5 – 0 XRN (1 Tie) Matrix Metrics: CTO 9 – 1 XRN

As of Nov 17, 2026, CTO Realty Growth, Inc. (CTO) is the stronger overall head-to-head candidate over XRN (XRN) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTO carries a Unified Composite Score of 40.9/100 (SELL) at $19.92 (122.0x Forward P/E, 24.6% operating margin), whereas XRN carries 45.3/100 (HOLD) at $25.79 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While XRN currently prints a higher short-term Unified Composite Score (45.3/100 HOLD vs. CTO 40.9/100 SELL), CTO captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (24.6% vs. N/A operating margin) and revenue trajectory (+24.3% vs. N/A YoY).
  • Technical & Structure Timing Caution: CTO is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.9); meanwhile XRN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CTO vs XRN
CTO NYSE Head-to-Head Winner
CTO Realty Growth, Inc.
Real Estate Investment Trusts
$19.92
-1.14% 1D
Market Cap $787.6M
TTM Revenue $170M
Forward P/E 122.0x
Beta / 30D Vol 0.04β · 27% Vol
Unified Composite Score
40.9 / 100 SELL
Tech 49.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -3.3%) with fading momentum, RSI 45
RSI-14: 44.9 · SMA20: $19.99 · SMA50: $20.32
XRN US Equity
XRN
Institutional Equity
$25.79
-2.35% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.50β · 47% Vol
Unified Composite Score
45.3 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 28
RSI-14: 28.5 · SMA20: $28.74 · SMA50: $32.14

6-Pillar Scorecard Institutional Category Breakdown (CTO 5 – 0 XRN)

Columns: Metric · CTO · XRN
1. Valuation Multiples CTO
Forward P/E 122.0x N/M
Trailing P/E 18.1x N/M
PEG Ratio N/M N/M
EV / Revenue 4.6x N/M
2. Growth & Scale CTO
Revenue Growth (YoY) +24.3% N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) $170M N/A
Market Cap $787.6M N/A
3. Profitability & Quality CTO
Gross Margin 74.4% N/A
Operating Margin 24.6% N/A
Net Profit Margin 26.1% N/A
Return on Equity (ROE) 7.2% N/A
4. Balance Sheet & Cash Flow CTO
Cash Generation (TTM) $104M EBITDA N/A
Cash Flow Margin 61.1% EBITDA Mgn N/A
Net Cash / Leverage $17.58 Book/Sh · 7.2% ROE N/A ROE
Dividend Yield 7.51% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 20.4% (13th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CTO
OpEx & R&D Intensity 49.8% of Rev ($85M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role REIT - Diversified Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CTO (9) vs XRN (1)
Institutional Metric CTO XRN Criterion Row Edge
Market Capitalization
Scale
$787.6M N/A Larger Scale CTO
Trailing P/E Ratio
Valuation
18.1x N/M Lower Multiple CTO
Forward P/E Ratio
Valuation
122.0x N/M Lower Multiple CTO
Revenue Growth (YoY)
Growth
+24.3% N/A Higher Growth CTO
Operating Margin (TTM)
Profitability
24.6% N/A Higher Margin CTO
Net Profit Margin
Profitability
26.1% N/A Higher Margin CTO
Return on Equity (ROE)
Capital Efficiency
7.2% N/A Higher ROE CTO
52-Week Range Position
Momentum
51% ($17–$23) 1% ($26–$39) Stronger Trend CTO
Beta / 30D Volatility
Risk Regime
0.04β · 27% Vol 0.50β · 47% Vol Lower Realized Risk CTO
Unified Institutional Score
Composite Signal
40.9 / 100 (SELL) 45.3 / 100 (HOLD) Higher Composite XRN
Trailing 12M Revenue (USD)
Operating Scale
$170M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
74.4% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.6x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$104M EBITDA ($17.58 Book/Sh · 7.2% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CTO +12.52 pp
CTO: -0.5% · XRN: -13.02%
3M Horizon CTO +20.47 pp
CTO: -9.58% · XRN: -30.05%
6M Horizon CTO +21.04 pp
CTO: -3.86% · XRN: -24.9%
1Y Horizon CTO +28.97 pp
CTO: +0.81% · XRN: -28.16%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CTO vs XRN. Trailing 12-month operating profitability (CTO 24.6% vs XRN N/A) and valuation multiples (CTO 122.0x vs XRN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CTO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$170M
Gross Margin74.4%
Op. Margin24.6%
ROE / Fwd P/E7.2% · 122.0x
XRN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CTO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 20.4%
IV Percentile 13th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CTO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
XRN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XRN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CTO Moat Profile Scale & Operating Efficiency Moat
REIT - Diversified Operator
Competes within the REIT - Diversified value chain with $787.6M market capitalization and 24.6% operating margin.
OpEx & R&D Reinvestment 49.8% of Rev ($85M)
90D Engineering Disclosures 0 Published
XRN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CTO vs XRN Key Questions & Quantitative Answers

As of Nov 17, 2026, CTO Realty Growth, Inc. (CTO) is the stronger overall head-to-head candidate over XRN (XRN) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTO carries a Unified Composite Score of 40.9/100 (SELL) at $19.92 (122.0x Forward P/E, 24.6% operating margin), whereas XRN carries 45.3/100 (HOLD) at $25.79 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While XRN currently prints a higher short-term Unified Composite Score (45.3/100 HOLD vs. CTO 40.9/100 SELL), CTO captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (24.6% vs. N/A operating margin) and revenue trajectory (+24.3% vs. N/A YoY). Technical & Structure Timing Caution: CTO is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.9); meanwhile XRN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CTO leads the Growth & Scale pillar: CTO posts +24.3% YoY revenue growth and N/A YoY earnings growth on $170M TTM revenue (74.4% gross margin, 24.6% operating margin), compared with XRN at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CTO generates $170M in USD-normalized revenue versus N/A for XRN. In operating R&D and SG&A reinvestment, CTO deploys 49.8% of Rev ($85M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XRN.

CTO screens cheaper on headline valuation multiples. CTO trades at 122.0x Forward P/E, 18.1x Trailing P/E, N/M PEG, and 4.6x EV/Revenue (61.1% EBITDA margin), whereas XRN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CTO (7.2% ROE) versus XRN (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, CTO carries 20.4% implied volatility (13th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 27% Vol realized risk). By comparison, XRN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 47% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.